Browse our anti-CCR5 (CCR5) Antibodies

Full name:
anti-C-C Chemokine Receptor Type 5 Antibodies (CCR5)
On are 507 C-C Chemokine Receptor Type 5 (CCR5) Antibodies from 35 different suppliers available. Additionally we are shipping CCR5 Kits (35) and CCR5 Proteins (12) and many more products for this protein. A total of 565 CCR5 products are currently listed.
AM4-7, CC-CKR-5, CCCKR5, CCR-5, CCR5, CD195, CKR-5, CKR5, CMKBR5, GPCR, IDDM22

All available anti-CCR5 Antibodies

Go to our pre-filtered search.

Top referenced anti-CCR5 Antibodies

  1. Human Monoclonal CCR5 Primary Antibody for FACS, ICC - ABIN4899075 : Alonzo, Kozhaya, Rawlings, Reyes-Robles, DuMont, Myszka, Landau, Unutmaz, Torres: CCR5 is a receptor for Staphylococcus aureus leukotoxin ED. in Nature 2013 (PubMed)
    Show all 17 references for 4899075

  2. Human Polyclonal CCR5 Primary Antibody for WB - ABIN265000 : Doranz, Lu, Rucker, Zhang, Sharron, Cen, Wang, Guo, Du, Accavitti, Doms, Peiper: Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1. in Journal of virology 1997 (PubMed)
    Show all 8 references for 265000

  3. Human Monoclonal CCR5 Primary Antibody for FACS - ABIN4895435 : Hartl, Krauss-Etschmann, Koller, Hordijk, Kuijpers, Hoffmann, Hector, Eber, Marcos, Bittmann, Eickelberg, Griese, Roos: Infiltrated neutrophils acquire novel chemokine receptor expression and chemokine responsiveness in chronic inflammatory lung diseases. in Journal of immunology (Baltimore, Md. : 1950) 2008 (PubMed)
    Show all 6 references for 4895435

  4. Human Monoclonal CCR5 Primary Antibody for FACS - ABIN1449163 : Nimura, Zhang, Okuma, Tanaka, Sunakawa, Yamamoto, Tanaka: Cross-linking cell surface chemokine receptors leads to isolation, activation, and differentiation of monocytes into potent dendritic cells. in Experimental biology and medicine (Maywood, N.J.) 2006 (PubMed)
    Show all 5 references for 1449163

  5. Human Monoclonal CCR5 Primary Antibody for FACS - ABIN4895433 : Maeda, Das, Yin, Tsuchiya, Ogata-Aoki, Nakata, Norman, Hackney, Takaoka, Mitsuya: Involvement of the second extracellular loop and transmembrane residues of CCR5 in inhibitor binding and HIV-1 fusion: insights into the mechanism of allosteric inhibition. in Journal of molecular biology 2008 (PubMed)
    Show all 4 references for 4895433

  6. Human Polyclonal CCR5 Primary Antibody for EIA, IF - ABIN372756 : Tan, Goedegebuure, Belt, Flaherty, Sankpal, Gillanders, Eberlein, Hsieh, Linehan: Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer. in Journal of immunology (Baltimore, Md. : 1950) 2009 (PubMed)
    Show all 2 references for 372756

  7. Human Monoclonal CCR5 Primary Antibody for FACS - ABIN119676 : Mueller, Kelly, Strange: Pathways for internalization and recycling of the chemokine receptor CCR5. in Blood 2002 (PubMed)

  8. Human Polyclonal CCR5 Primary Antibody for IHC, ELISA - ABIN1532235 : Samson, Labbe, Mollereau, Vassart, Parmentier: Molecular cloning and functional expression of a new human CC-chemokine receptor gene. in Biochemistry 1996 (PubMed)

  9. Cow (Bovine) Polyclonal CCR5 Primary Antibody for WB - ABIN2779385 : Catano, Agan, Kulkarni, Telles, Marconi, Dolan, Ahuja: Independent effects of genetic variations in mannose-binding lectin influence the course of HIV disease: the advantage of heterozygosity for coding mutations. in The Journal of infectious diseases 2008 (PubMed)

More Antibodies against CCR5 Interaction Partners

Mouse (Murine) C-C Chemokine Receptor Type 5 (CCR5) interaction partners

  1. The upregulation of CCR5 on the surface of the CD8 (show CD8A Antibodies)(+) T cells increases the number of contacts with Ag-bearing dendritic cells, which ultimately results in increased CD8 (show CD8A Antibodies)(+) T cell response to Ag rechallenge.

  2. CCL4 (show CCL4 Antibodies)-CCR5 axis can contribute to breast cancer metastasis to bone by mediating the interaction between cancer cells and fibroblasts in bone cavity.

  3. Cytokine-induced killer cells interact with tumor lysate-pulsed dendritic cells via CCR5 signaling.

  4. this study shows that diosgenin-mediated anti-allergic effects are associated with increased number of Foxp3 (show FOXP3 Antibodies)+ Treg cells expressing CCR5

  5. CCR5 deficiency increased the production of TNF-alpha (show TNF Antibodies) following LPS (show TLR4 Antibodies) treatment through increased activation of the p38 (show CRK Antibodies) pathway in the kidney, resulting in renal apoptosis and leukocyte infiltration and led to exacerbation of LPS (show TLR4 Antibodies)-induced acute kidney injury.

  6. In West Nile virus infection of the central nervous system, CCR5 activity is required to limit viral burden in the cerebral cortex.

  7. CCR5 blockade suppresses B16 melanoma growth by inhibiting of IL-6 (show IL6 Antibodies)-Stat3 (show STAT3 Antibodies) signaling pathway via upregulation of SOCS3 (show SOCS3 Antibodies).

  8. Data show that the activation of mammalian target of rapamycin (show FRAP1 Antibodies) complex mTORC1 during encephalomyocarditis virus infection is chemokine (C-C) receptor 5-dependent and promotes the translation of inducible NO synthase (iNOS (show NOS2 Antibodies)) and cyclooxygenase (COX)-2 (show COX2 Antibodies).

  9. CCL5 (show CCL5 Antibodies)-induced endothelial progenitor cell migration was increased by overexpression of CCR5 and that increase was abolished by addition of CCL5 (show CCL5 Antibodies) antibody, suggesting CCL5 (show CCL5 Antibodies)/CCR5 interaction is involved in chemotactic effects of endothelial progenitor cells.

  10. These findings show that migration and activation of immune cells via CCR5 is required for controlling N. caninum parasites during the early phase of the infection.

Cow (Bovine) C-C Chemokine Receptor Type 5 (CCR5) interaction partners

  1. Transcript analysis showed that antigen stimulation of WC1(+)gammadelta T cells substantially increased CCR5 expression.

Rhesus Monkey C-C Chemokine Receptor Type 5 (CCR5) interaction partners

  1. CCR5 inhibition may provide a cardioprotective benefit in SIV infection by preventing cardiomyocyte CCR5 signaling.

  2. A vaccine against CCR5 protects a subset of macaques upon intravaginal challenge with simian immunodeficiency virus SIVmac251.

  3. CCR5 downregulation on CD4(+) T cells by TCR activation has no measurable effect on susceptibility to SAIDS.

  4. CD4 and CD8 T cells are more vulnerable to SIV infection, indicating the the ability to express CCR5 may activate and hassten T cell death by SIV infection in vitro.

  5. Results estimate the infectivity of CCR5-tropic simian immunodeficiency virus SIV(mac251) in the gut (show GUSB Antibodies).

  6. observed a significantly higher loss of CCR5(+) CD45RA(-) CD4 (show CD4 Antibodies)(+) T cells in CD8 (show CD8A Antibodies)(+) lymphocyte-depleted macaques than in controls

  7. Virus recovered from CA28 plasma (SHIV(CA28NP)) used both CCR5 and CXCR4 (show CXCR4 Antibodies) for entry, but the virus recovered from lymph node (SHIV(CA28NL)) used CXCR4 (show CXCR4 Antibodies) almost exclusively

Human C-C Chemokine Receptor Type 5 (CCR5) interaction partners

  1. Env (show ERVW-1 Antibodies) regions that respond to CCR5 binding was located in the gp120 (show ITIH4 Antibodies) alpha1 helix and in the gp41 HR1 heptad repeat and membrane-proximal external region.

  2. A frameshift mutation in CCR5 was associated, but not significantly, with sporadic inclusion body myositis.

  3. study revealed that while HIV-1 gp120 (show ITIH4 Antibodies) and Staph aureus LukED both target CCR5, they bind to different regions of the receptor, highlighting the divergence of the pathogens

  4. Genetic variation of CCR5 gene demonstrates a possible association with hypertension, diabetes mellitus and atherosclerosis comorbidity in patient treated with hemodialysis.

  5. Findings indicate the importance of chemokine (CC motif) ligand 5 (CCL5 (show CCL5 Antibodies)) genetic variability and CCL5 (show CCL5 Antibodies)-CCR5 (CC chemokine receptor 5) axis on the susceptibility to HCV.

  6. The transferred nuclear Overhauser effect (TRNOE) crosspeaks in the ternary complex were assigned to the specific Tyr (show TYR Antibodies) protons in the human C-C chemokine receptor 5 (CCR5) chemokine receptor (show CCR1 Antibodies) peptide and to methyl protons, predominantly of isoleucine residues, and also of leucine and/or valine residues of HIV-1 gp120 (show ITIH4 Antibodies) envelope protein.

  7. Intermolecular interactions of RANTES (show CCL5 Antibodies) with its receptor CCR5 have been reported based on NMR spectroscopy measurements.

  8. Binding of J113863 to CCR2 (show CCR2 Antibodies) or CCR5 also induced the recruitment of beta-arrestin 2 (show ARRB2 Antibodies), whereas UCB35625 did not. UCB35625 induced the chemotaxis of L1.2 cells expressing CCR2 (show CCR2 Antibodies) or CCR5. In contrast, J113863 induced the migration of L1.2-CCR2 (show CCR2 Antibodies) cells but antagonized the chemokine (show CCL1 Antibodies)-induced migration of L1.2-CCR5 cells.

  9. The higher frequency of CCR5 wild-type allele among leishmaniasis patients may suggest an increased risk of HIV infection and also support its facilitative role in Leishmania infection

  10. CCR5 is reduced following low-intensity strength exercise with blood flow restriction.

CCR5 Antigen Profile

Antigen Summary

This gene encodes a member of the beta chemokine receptor family, which is predicted to be a seven transmembrane protein similar to G protein-coupled receptors. This protein is expressed by T cells and macrophages, and is known to be an important co-receptor for macrophage-tropic virus, including HIV, to enter host cells. Defective alleles of this gene have been associated with the HIV infection resistance. The ligands of this receptor include monocyte chemoattractant protein 2 (MCP-2), macrophage inflammatory protein 1 alpha (MIP-1 alpha), macrophage inflammatory protein 1 beta (MIP-1 beta) and regulated on activation normal T expressed and secreted protein (RANTES). Expression of this gene was also detected in a promyeloblastic cell line, suggesting that this protein may play a role in granulocyte lineage proliferation and differentiation. This gene is located at the chemokine receptor gene cluster region. Two transcript variants encoding the same protein have been found for this gene.

Alternative names and synonyms associated with CCR5

  • chemokine (C-C motif) receptor 5 (Ccr5) antibody
  • chemokine (C-C motif) receptor 5 (CCR5) antibody
  • chemokine (C-C motif) receptor 5 (gene/pseudogene) (CCR5) antibody
  • AM4-7 antibody
  • CC-CKR-5 antibody
  • CCCKR5 antibody
  • CCR-5 antibody
  • CCR5 antibody
  • CD195 antibody
  • CKR-5 antibody
  • CKR5 antibody
  • CMKBR5 antibody
  • GPCR antibody
  • IDDM22 antibody

Protein level used designations for CCR5

C-C CKR-5 , C-C chemokine receptor type 5 , CC-CKR-5 , CCR-5 , MIP-1 alpha receptor , chemokine (C-C) receptor 5 , C-C chemokine receptor 5 , CC chemokine receptor 5 , chemokine C-C motif receptor 5 , chemokine (C-C motif) receptor 5 , C-C motif chemokine receptor 5 A159A , HIV-1 fusion coreceptor , chemokine receptor CCR5 , chemr13

12774 Mus musculus
117029 Rattus norvegicus
100101579 Oryctolagus cuniculus
484789 Canis lupus familiaris
497017 Bos taurus
735311 Macaca mulatta
100126710 Papio anubis
450128 Pan troglodytes
100190809 Pongo abelii
1234 Homo sapiens
Selected quality suppliers for anti-CCR5 (CCR5) Antibodies
Did you look for something else?